Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL989899

CN1[C@@H]2CC[C@H]1C[C@@H](Nc1ccc(-c3ccc4cc[nH]c4c3)nc1)C2.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.41
CHRNA7 P36544 3/20 0.41
GHSR Q92847 1/20 0.39
MPO P05164 4/20 0.37
SYK P43405 2/20 0.37
KAT2B Q92831 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PIP4K2A P48426 1/20 0.35
PIP4K2B P78356 1/20 0.35
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL989901 1.00 KCNH2 (0.41) KCNH2CHRNA7GHSRMPOSYK
SCHEMBL743913 0.91 KCNH2 (0.47) KCNH2CHRNA7GHSRMPOSYK
SCHEMBL743914 0.91 KCNH2 (0.47) KCNH2CHRNA7GHSRMPOSYK
Trifluoroacetic Acid SCHEMBL2486288 0.88 KCNH2 (0.43) KCNH2CHRNA7MPOSYKKAT2B
Trifluoroacetic Acid SCHEMBL2486287 0.88 KCNH2 (0.43) KCNH2CHRNA7MPOSYKKAT2B
Trifluoroacetic Acid SCHEMBL744720 0.86 CHRNA7 (0.47) KCNH2CHRNA7SYKGSK3BDYRK1A
SCHEMBL745267 0.84 CHRNA7 (0.48) KCNH2CHRNA7KAT2BPIP4K2APIP4K2B
SCHEMBL745268 0.84 CHRNA7 (0.48) KCNH2CHRNA7KAT2BPIP4K2APIP4K2B
Hydrochloric Acid SCHEMBL746659 0.83 CHRNA7 (0.48) KCNH2CHRNA7KAT2BPIP4K2APIP4K2B
Hydrochloric Acid SCHEMBL746658 0.83 CHRNA7 (0.48) KCNH2CHRNA7KAT2BPIP4K2APIP4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7872017-B2 Fused bicycloheterocycle substituted azabicyclic alkane derivatives ABBOTT LABORATORIES (US) 2011-01-18 US disclosed
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives ABBOTT LABORATORIES (US) 2010-12-02 US disclosed
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES ABBVIE INC. 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045539-A1 FUSED BICYCLOHETEROCYCLE SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES MALT1, BMP2, ALKBH2 KCNH2 708/4885CHRNA7 2776/4885GHSR 3508/4885
US-20100305089-A1 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives MALT1, BMP2, ALKBH2 KCNH2 708/4885CHRNA7 2776/4885GHSR 3508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.